Previous Article | Next Article 
Infection and Immunity, October 2000, p. 5998-6004, Vol. 68, No. 10
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Saccharomyces boulardii Preserves the
Barrier Function and Modulates the Signal Transduction Pathway Induced
in Enteropathogenic Escherichia coli-Infected T84
Cells
Dorota
Czerucka,1,*
Stephanie
Dahan,1
Baharia
Mograbi,2
Bernard
Rossi,2 and
Patrick
Rampal1
Laboratoire de Gastroentérologie et
Nutrition1 and INSERM U364, IFR50,
Faculté de Médecine,2
Université de Nice-Sophia Antipolis, 06107 Nice Cedex 2, France
Received 24 February 2000/Returned for modification 30 March
2000/Accepted 6 June 2000
 |
ABSTRACT |
Use of the nonpathogenic yeast Saccharomyces boulardii
in the treatment of infectious diarrhea has attracted growing interest. The present study designed to investigate the effect of this yeast on
enteropathogenic Escherichia coli (EPEC)-associated disease demonstrates that S. boulardii abrogated the alterations
induced by an EPEC strain on transepithelial resistance,
[3H]inulin flux, and ZO-1 distribution in T84 cells.
Moreover, EPEC-mediated apoptosis of epithelial cells was delayed in
the presence of S. boulardii. The yeast did not modify the
number of adherent bacteria but lowered by 50% the number of
intracellular bacteria. Infection by EPEC induced tyrosine
phosphorylation of several proteins in T84 cells, including p46 and p52
SHC isoforms, that was attenuated in the presence of S. boulardii. Similarly, EPEC-induced activation of the ERK1/2
mitogen-activated protein (MAP) kinase pathway was diminished in the
presence of the yeast. Interestingly, inhibition of the ERK1/2 pathway
with the specific inhibitor PD 98059 decreased EPEC internalization,
suggesting that modulation of the ERK1/2 MAP pathway might account for
the lowering of the number of intracellular bacteria observed in the
presence of S. boulardii. Altogether, this study
demonstrated that S. boulardii exerts a protective effect
on epithelial cells after EPEC adhesion by modulating the signaling
pathway induced by bacterial infection.
 |
INTRODUCTION |
Saccharomyces boulardii
is a thermophilic, nonpathogenic yeast administered in Western Europe
for the prevention and treatment of a variety of diarrheal diseases
(17, 29). However, the mechanisms by which S. boulardii controls diarrhea remain elusive. The efficacy of this
yeast has been attributed to several of its properties, such as its
effect on the mucosa leading to an increase in dissaccharidase activity
(8) or stimulation of the immune response (7). In
animals, administration of S. boulardii provides protection
against intestinal lesions caused by several diarrheal pathogens
(10, 33). In vitro studies have demonstrated that S. boulardii exerts antagonistic activity against various bacterial pathogens (6). Recent studies have reported the adhesion of the Salmonella enterica serovars Typhimurium and Enteritis
and of enteropathogenic Escherichia coli (EPEC) and
enterohemorrhagic E. coli to S. boulardii
(24, 25).
EPEC is a major cause of diarrhea in the developing world (31,
34). The pathogenesis of EPEC infections involves a three-stage process. (i) EPEC adheres initially to intestinal epithelial cells in a
pattern described as localized adherence (36). This pattern of adherence, characterized by microcolonies of bacteria associated with the epithelial cells, is dependent on the expression of the bacterial type IV bundle-forming pilus (BFP) (3). (ii) Next, the bacteria induce signal transduction pathways in host cells, leading
to an elevation in the intracellular levels of Ca2+ and
inositol triphosphate (16, 23) and the phosphorylation of
cellular proteins (4, 35, 41). (iii) These signaling events
culminate in the formation of attaching-and-effacing lesions which are
characterized by localized degeneration of the microvilli, intimate
contact between the bacteria and the infected cell, and the
assembly of highly organized cytoskeletal structures in the epithelial
cells just beneath the attached bacteria, forming cuplike pedestals
(22, 27, 30). EPEC is also able to induce its internalization by nonphagocytic epithelial cells (2, 15).
The aim of our study was to investigate in vitro the effect of S. boulardii against EPEC infection using the T84 cell line derived
from a colon carcinoma. This cell line has been extensively used to
elucidate the mechanism of EPEC-induced diarrhea. EPEC infection
results in a modification of the T84 barrier function, characterized by
a drop in transepithelial resistance, an increase in permeability, and
modification of the distribution of the tight junction-associated
protein ZO-1 (32, 37). Our study reveals that S. boulardii maintains the barrier function and the viability of
EPEC-infected T84 cells. Although the yeast does not modify the number
of cell-associated bacteria, it reduces the number of intracellular
bacteria. The phosphorylation of several proteins induced by EPEC in
T84 cells is diminished in the presence of S. boulardii.
Finally, the yeast interferes with the ERK1/2 mitogen-activated protein
(MAP) kinase pathway that, as demonstrated in this study, is implicated
in the invasive process of EPEC.
 |
MATERIALS AND METHODS |
Cell line, media, and bacterial and yeast strains.
The human
colon T84 cell line was obtained from the European Collection of Animal
Cell Cultures (Salisbury, England). The T84 culture medium contained a
1:1 mixture of Dulbecco-Vogt modified Eagle medium and Ham's F-12
medium (DMEM-F-12) supplemented with 50 µg of penicillin and 50 µg
of streptomycin (Sigma) per ml and 5% fetal bovine serum (DAP). The
bacterial wild-type (WT) strain E2348/69 (kindly provided by J. Kaper,
Center for Vaccine Development, University of Maryland, Baltimore) was
grown overnight in Luria-Bertani medium at 37°C, without shaking. The
yeast S. boulardii (Laboratories Biocodex, Paris, France)
was grown at 37°C, with shaking, in Halvorston minimal medium with
2% glucose.
Inhibitor.
The MEK1 inhibitor PD 98059 (1)
(Calbiochem) was stored in dimethyl sulfoxide (DMSO) at
20°C.
Electrical resistance measurements.
T84 cells were grown on
4.6-cm2 porous filter membranes (0.4-µm pores; Nunc).
Transmonolayer electrical resistance (TER) was measured with the
Millicell-ERS apparatus (Millipore, Molsheim, France) as described
previously (21). Under these conditions, high TER values
(>1,000
·cm2) were consistently obtained in 14-day
postseeding monolayers.
Infection of filter-grown T84 monolayers with EPEC.
Prior to
infection, the T84 medium was changed to medium without serum and
antibiotics (DMEM-F-12). As previously reported (41),
approximately 108 EPEC (or 100 bacteria/cell) were added to
the apical surface of T84 monolayers and incubated at 37°C in a 5%
CO2, water-jacketed incubator. When infection was performed
in the presence of yeast, 10 yeasts/cell were added. This ratio did not
modify intestinal cell viability (13). At the indicated
times, transepithelial resistance, bacterial adhesion and invasion,
inulin passage, and ZO-1 distribution were measured as described hereafter.
Adhesion and invasion assays.
Bacterial adhesion to T84
cells was quantified using the plate dilution method (35).
Briefly, at the times of infection indicated in the legend to Table 1,
bacteria present in the culture medium were eliminated by extensive
washes with sterile phosphate-buffered saline (PBS). Cells were then
trypsinized and lysed in water containing 0.1% bovine serum albumin
(BSA). The cell lysates contained "cell-associated bacteria"
corresponding to adherent as well as intracellular bacteria. For the
determination of invasion, after PBS washes, monolayers were incubated
for an additional hour with DMEM-F-12 containing 100 µg of
gentamicin per ml. Since gentamicin was not concentrated in epithelial
cells, intracellular bacteria survived to the incubation, while
adherent and extracellular bacteria were killed (19). The
monolayers were then washed with sterile PBS, and epithelial cells with
intracellular bacteria were detached by trypsin and lysed as described
elsewhere (35). The percentage of invasion was calculated as
follows: percent invasion = number of intracellular bacteria/number of cell-associated (adherent and intracellular) bacteria.
Distribution of ZO-1.
ZO-1 distribution was analyzed after
infection using immunochemistry and confocal microscopy. At the times
indicated, the monolayers were washed extensively with PBS and fixed
with 2% paraformaldehyde for 30 min. The cells were permeabilized with 0.1% Triton X-100 in PBS for 5 min and then washed with PBS.
Polyclonal rabbit anti-ZO-1 antibody (Zymed 61-7300) was incubated with
the permeabilized cells for 45 min at 37°C. The monolayers were
washed and then treated with fluorescein-conjugated anti-rabbit
immunoglobulin G (Dakopatts F205) for 45 min at 37°C. After washes
with PBS, the filters were excised from the supports, mounted, and
observed under a Zeiss confocal laser scanning microscope.
Measurement of [3H]inulin passage.
Polarized
monolayers of filter-grown T84 cells were infected with EPEC for 3 h as described above. After measurement of transepithelial resistance,
220,000 cpm of [3H]inulin (Mr,
5,200; hydrodynamic diameter, 11.5 Å; Amersham) was added to the
apical surface. Unlabeled inulin (0.5 mM) was present in both apical
and basolateral incubation medium. After a 2-h equilibration period,
100 µl (5%) of the basolateral fluid was removed at 1-h intervals
and counted.
Preparation of cell lysates for Western blotting and
immunoprecipitation.
T84 cells were seeded in 100-mm petri tissue
culture dishes. At 70 to 90% confluence, the monolayers were washed
twice with serum-free DMEM-F-12 and then grown in fresh culture medium
supplemented with 0.1% BSA (Sigma A7030) for 12 h. Infection was
carried out by the addition of 500 µl of a late-logarithmic bacterial
culture (100 bacteria/cell) alone or in the presence of S. boulardii (10 yeasts/cell). At the times indicated, the infected
cells were washed with PBS and solubilized for 30 min at 4°C in lysis
buffer (50 mM Tris-HCl, pH 7.5; 150 mM NaCl; 1% Nonidet P-40
[NP-40]; 2 mM Na3VO4; 1 mM EDTA; 1 µM
aprotinin; 25 µM leupeptin; 1 µM pepstatin; 1 mM AEBSF; 10 mM NaF;
5 mM sodium PPi; 10 mM
-glycerophosphate). The lysate
was sonicated and centrifuged at 15,000 rpm for 15 min at 4°C. The
protein content of the supernatant was determined using Bio-Rad DC
reagents. Immunoprecipitation and Western blotting were carried out as
previously described (5).
Statistical analysis.
Results are presented as the mean ± the standard error of the mean (SEM). Tests of statistical
significance were done by analysis of variance with the StatView
program for Macintosh followed by the post hoc comparison with the
Bonferroni-Dunn tests.
 |
RESULTS |
S. boulardii prevents the EPEC-induced decrease of T84
monolayer resistance.
To determine the effect of S. boulardii on the EPEC-induced decrease of transepithelial
resistance, T84 monolayers were apically infected with the E2348/69
strain alone or in the presence of S. boulardii, and the
transepithelial resistance was monitored over 12 h. As shown in
Fig. 1, incubation of T84 monolayers with S. boulardii alone had no effect on transepithelial
resistance. In EPEC-infected cells, monolayer resistance was unchanged
up until 4 h; at 6 h it had dropped significantly to 767 ± 84
·cm2 (P < 0.02 versus control
monolayers) and reached a plateau by 12 h of infection. In
contrast, when infection was performed in the presence of S. boulardii, the transepithelial resistance remained at the level of
uninfected monolayers up until 9 h of infection. At 12 h of
infection, the resistance of these monolayers dropped slightly but did
not differ significantly from control monolayers (P > 0.05). The barrier function and the viability of EPEC-infected T84
cells were thus preserved in the presence of S. boulardii.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 1.
S. boulardii prevents EPEC-induced decrease
of transepithelial resistance in T84 monolayers. Bacteria (100 bacteria/cell) and yeast (10 yeasts/cell) were added to the apical
surface of T84 cells. Resistance decreased in cells infected with EPEC
alone ( ) but remained comparable to control monolayers ( ) in
cells infected in the presence of S. boulardii ( ).
S. boulardii alone did not affect the transepithelial
resistance of T84 monolayers during the time of these experiments
( ). Each point represents the mean value obtained from at least six
individual T84 monolayers. Error bars show the standard deviation. The
asterisk denotes a significant difference versus the control monolayers
(P < 0.02) when compared by the Bonferroni-Dunn
tests.
|
|
S. boulardii maintains the tight-junction structure of
EPEC-infected T84 cells.
The decrease in transepithelial
resistance is associated with the disruption of actin filaments and
thereby with morphological modification of the structure of the tight
junctions. To investigate the effect of S. boulardii on
EPEC-induced changes in tight-junction structure, confocal microscopy
was used to analyze the distribution of Zonula Occludens (ZO-1), a
tight-junction-associated protein, in cells infected by E2348/69 alone
or in the presence of yeast. Uninfected T84 monolayers exhibited (Fig.
2A) a well-defined ZO-1 staining pattern
in the perijunctional region that remained unchanged in cells
maintained in the presence of S. boulardii (Fig. 2B). In
contrast, T84 monolayers infected for 6 h with E2348/69 showed diffuse ZO-1 staining (Fig. 2C) that disappeared after 12 h of infection (Fig. 2E). In contrast, ZO-1 protein distribution was preserved in cells infected by EPEC for 6 h (Fig. 2D) and 12 h (Fig. 2F) in the presence of S. boulardii, strongly
supporting a protective role of S. boulardii on the tight
junction structure in EPEC-infected T84 monolayers.

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 2.
Representative confocal laser scanning micrographs
(z-series, overlay) of T84 cell monolayers immunostained for ZO-1 with
antibodies for this protein, followed by secondary antibodies
conjugated to fluorescein isothiocyanate. (A and B) Normal distribution
of ZO-1 in uninfected cells (A) and in cells exposed to S. boulardii (B). (C and E) Monolayers infected with E2348/69 alone
for 6 h (C) and 12 h (E). (D and F) Monolayers infected for
6 h (D) or 12 h (F) in the presence of S. boulardii. Original magnification, ×2,400. The same results were
obtained at least three times.
|
|
S. boulardii reduces the [3H]inulin flux
in EPEC-infected T84 cells.
In intestinal epithelium, paracellular
transport of molecules was under the control of tight junctions. Inulin
(an inert compound with a molecular weight of 5,200 and an 11.5-Å
radius) has been used as a marker of the gate function of tight
junctions. To further examine the effect of S. boulardii on
EPEC-induced changes in paracellular transport,
[3H]inulin was added to the apical surface of T84
monolayers infected for 6, 12, and 24 h with E2348/69 alone or in
the presence of S. boulardii. Inulin flux was measured by
assaying the radioactivity that crossed the monolayers to the
basolateral medium. As expected, [3H]inulin did not
penetrate uninfected T84 monolayers with a high electrical resistance
(Table 1). In monolayers infected for 12 and 24 h, [3H]inulin passage was significantly
increased compared to control monolayers. In cells infected by EPEC in
the presence of S. boulardii, [3H]inulin
passage through T84 monolayers was significantly lower. This result
indicates that the gate function of tight junctions was maintained in
cells infected in the presence of yeast. Since increasing inulin flux
was associated with cell death (28), this prompted us to
investigate the effect of S. boulardii on EPEC-induced
apoptosis.
S. boulardii prevents the caspase-3 activation induced
by EPEC in T84 cells.
Programmed cell death, or apoptosis, can be
initiated by a wide variety of stresses, including bacterial infection
(42). The caspases are proteases that play a key role in the
initiation and the execution of apoptosis. Among them, cpp32
(caspase-3) is the most extensively studied apoptotic caspase. It is
synthesized as an inactive proenzyme of 32 kDa that is cleaved in cells
undergoing apoptosis into two active forms of 12 and 20 kDa. We
therefore investigated the generation of the active form of cpp32 (p20) in T84 cells infected by EPEC alone or in the presence of S. boulardii. As shown in Fig. 3B, the
yeast alone did not induce the cleavage of cpp32 in T84 cells,
indicating that S. boulardii did not affect cell viability.
By contrast, accumulation of the activated p20cpp32 form
was visualized after 6 h in cells infected with EPEC alone (Fig.
3C) but was absent in cells infected in the presence of S. boulardii (Fig. 3D). When yeast was present, the
p20cpp32 form was detectable only after 8 h of
infection. These results indicate that the apoptotic program induced by
EPEC infection in T84 cells is delayed in the presence of yeast.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
S. boulardii delays the activation of
caspase-3 in EPEC-infected cells. T84 cells were infected with E2348/69
alone (C) or in the presence of S. boulardii (D). After
various periods of infection, the cells were lysed and samples were
resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) using a 9% polyacrylamide gel and analyzed by
immunoblotting using anti-cpp32 antibody. The anti-caspase-3 recognizes
the 32-kDa proform and the 20-kDa intermediate active form. (A) Control
cells. (B) Cells incubated for various times with S. boulardii alone. The same results were obtained at least three
times.
|
|
S. boulardii does modify the number of intracellular
bacteria.
Since adhesion to intestinal cells is the first step in
EPEC pathogenicity, we investigated the effect of S. boulardii on the number of bacteria adherent to T84 cells. The
data in Table 2 reveal that S. boulardii did not modify the number of cell-associated (adherent
and intracellular) bacteria. EPEC has been shown to be invasive in some
culture systems (2, 15, 35). The invasion assay was
therefore performed using gentamicin on cells infected in the absence
or presence of S. boulardii. Use of this standard assay
revealed that the number of intracellular bacteria recovered in T84
cells infected with EPEC alone ([4.38 ± 0.72] × 104 CFU/well) was significantly decreased, by 50%
([2.2 ± 0.41] × 104 CFU/well), in cells infected
in the presence of S. boulardii.
S. boulardii alters EPEC-induced tyrosine
phosphorylation of T84 proteins.
Bacteria trigger signals into the
host cells that lead to their internalization (4). The
decrease in the number of intracellular bacteria in the presence of
S. boulardii prompted us to investigate the effect of the
yeast on EPEC-induced transduction signals. The time course of
infection showed that 1 h of infection is sufficient to induce
protein tyrosine phosphorylation in T84 cells (data not shown).
Therefore, T84 cells were infected for 1 h with EPEC alone or in
the presence of yeast, and the whole-cell lysates were analyzed by
anti-phosphotyrosine (
P-Tyr) Western blotting (Fig.
4A). In agreement with results obtained
in EPEC-infected HeLa cells (35), EPEC infection of T84
cells induced the phosphorylation of several proteins (indicated by
arrows in Fig. 4A). These proteins presented various molecular sizes:
130, 120, 100, 90, 72, 64, 60, 52, and 39 kDa. Coinfection in the
presence of the yeast significantly decreased the degree of
phosphorylation of most of these proteins, supporting the idea that
S. boulardii might modify cellular response(s) to EPEC
infection.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 4.
S. boulardii significantly affects
EPEC-induced signaling in T84 cells. (A) T84 cells were infected with
E2348/69 alone or in the presence of yeast cells. After a 1-h
infection, the cells were lysed and samples were resolved by SDS-PAGE
using a 9% polyacrylamide gel and analyzed by immunoblotting with
P-Tyr antibody. The control lane corresponds to uninfected cells. A
positive control lane was obtained using cells treated for 15 min with
10 nM EGF. The positions of the molecular mass standards are shown on
the left of the blot in kilodaltons. The proteins phosphorylated in
infected T84 cells are indicated by arrows. (B) Lysates from uninfected
T84 cells (control) and cells infected for 1 h with the WT strain
(E2348/69) alone or in the presence of S. boulardii were
immunoprecipitated with anti-SHC antibody. The immunocomplex was
subjected to SDS-PAGE using a 9% polyacrylamide gel and then analyzed
by immunoblotting using P-Tyr antibody. A positive control was
obtained using cells treated for 15 min with 10 nM EGF. The same
results were obtained at least three times.
|
|
S. boulardii modifies tyrosine phosphorylation of SHC
in T84 cells infected by the WT EPEC strain.
The
anti-phosphotyrosine antibody reacted strongly with protein localized
at a molecular mass of 52 kDa (Fig. 4A). This protein presented the
same electrophoretic mobility as the major phosphorylated protein in
EGF-treated T84 cells. Phosphorylation of this protein was
significantly decreased in T84 cells infected in the presence of
S. boulardii. In order to verify that this phosphoprotein
corresponded to p52 SHC, immunoprecipitation was performed using an
anti-SHC antibody, followed by
P-Tyr Western blotting. The results
presented in Fig. 4B showed tyrosine phosphorylation of the p46 and p52 SHC isoforms in cells infected for 1 h with EPEC and in epidermal growth factor (EGF)-treated cells used as a positive control. Since
phosphorylation of the p46 and p52 SHC isoforms was significantly decreased in cells infected in the presence of yeast, S. boulardii can thus downregulate the SHC downstream cellular
response induced in T84 cells by EPEC infection.
S. boulardii decreases the activation of ERK1/2 MAP
kinases by the WT EPEC strain.
Since SHC is an upstream regulatory
protein of the ERK1/2 MAP kinase pathway, the effect of the yeast on
activation of the ERK1/2 pathway was thus investigated by Western
blotting using an antiphosphorylated ERK1/2 antibody (Fig.
5). The activated forms of ERK1/2 were
not detected in cell lysates obtained after a 1-h incubation with
S. boulardii alone. Consistent with the SHC phosphorylation,
active forms of ERK1/2 (p42 and p44) were present in cells infected for
1 h by EPEC. When infection was performed in the presence of
S. boulardii, phosphorylation of both ERK1 and ERK2 was
significantly decreased. Western blotting using a nonphosphorylated
form of ERK1/2 revealed the presence of the same amount of these
proteins (p42 and p44) (data not shown). S. boulardii thus
decreased the activation of ERK1/2 induced by EPEC infection of T84
cells.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 5.
S. boulardii prevents the activation of
ERK1/2 kinases in E2348/69-infected cells. T84 cells were infected with
the WT strain E2348/69 alone or in the presence of S. boulardii. After 1 h of infection, cells were lysed and
samples were resolved by SDS-PAGE using a 9% polyacrylamide gel and
then analyzed by immunoblotting with anti-phosphorylated ERK1/2
antibodies. The control line corresponds to uninfected T84 cells. A
positive control was obtained using cells treated for 15 min with 10 nM
EGF. The same results were obtained at least three times.
|
|
Inhibition of invasion by PD 98059 treatment: correlation of
invasion with the activation of ERK1/2 pathway.
Since we have
shown that S. boulardii decreased both EPEC invasion and
EPEC-induced MAP activation and since activation of ERK1/2 kinases has
been implicated in the invasion of Listeria monocytogenes
(38), we therefore addressed whether the activation of
ERK1/2 MAP kinases could be involved in the invasion process of EPEC.
To this end, T84 cells were preincubated for 90 min with 50 µM
PD98059, an MEK1-ERK1/2 pathway inhibitor, prior to being exposed to
bacterial infection. Even though PD98059 did not modify the number of
cell-associated bacteria, EPEC invasion was reduced by 60% in cells
incubated with PD98059 (Table 3),
indicating that ERK1/2 MAP kinase activation was involved in the
invasion process of EPEC into T84 cells.
 |
DISCUSSION |
Monolayers of cultured polarized epithelial cells grown on filters
were used to demonstrate that EPEC interaction with the apical cell
surface induced a marked decrease in transepithelial resistance.
Interestingly, S. boulardii prevented the decrease of
transepithelial electrical resistance in EPEC-infected T84 cells. Since
transepithelial resistance reflects the barrier function and the
viability of monolayers, we investigated whether S. boulardii preserves these two parameters in infected T84 cells. In
EPEC-infected cells, alteration of the tight junction structure
modifies epithelial permeability to solutes transported through the
paracellular pathway (32). Since tight junctions are size
selective, the flux of inulin (a molecule with an 11.5-Å radius versus
6.7 Å for mannitol) increases only after a long period of infection
(12 and 24 h), when the transepithelial resistance has been
considerably lowered. Inulin flux was significantly attenuated in cells
infected in the presence of yeasts. Since paracellular permeability to
inert probes reflects the gate function of tight junctions (11,
28), the decrease in inulin flux suggests that damage to the
intercellular tight junction caused by EPEC infection was reduced in
the presence of yeasts. This observation was supported by the
immunolocalization of ZO-1. This tight-junction-associated protein
disappeared in cells infected with EPEC alone but remained present in
cells when infection was performed in the presence of yeast.
Since inulin flux also reflects the killing effect of EPEC on T84 cells
(28), the fact that the yeast lowered this flux suggests
that cell viability is preserved when S. boulardii is present during the infection period. Increasing numbers of bacterial pathogens have been identified as mediators of apoptosis in vitro (42). Recently, Crane et al. (12) demonstrated
that EPEC-infected cells died by apoptosis. The data presented in this
study, based on detection of the active form of caspase-3, confirms
this observation. EPEC triggers activation of this proapoptotic
protease in T84 cells. When infection was performed in the presence of
yeast cells, caspase activation by EPEC was delayed, indicating that
S. boulardii protects T84 cells. Moreover, the active form
of caspase was not detected in cells incubated with yeast cells alone.
This observation, together with the fact that the yeast alone did not
modify transepithelial resistance, demonstrates that T84-cell viability
is not affected by incubation with S. boulardii. The
protective effect of S. boulardii in EPEC infection of T84
cells prompted us to investigate the mechanism of action of this yeast.
Adhesion of EPEC to S. boulardii was recently reported by
Gedek et al. (24, 25). Because S. boulardii does
not permanently colonize animals or humans with normal flora
(29), these authors proposed that the bacteria that bind the
yeast are eliminated. Aggregation of the yeasts and bacteria is
mediated by the bacterial type I pili and the mannose residues on the
S. boulardii cell wall (24). EPEC adhesion to
epithelial cells is mediated by type IV BFP, which is not inhibited by
mannose; mannose-resistant adhesiveness to epithelial cells is
considered a strong indication of enteropathogenicity for E. coli (34). Thus, the cell wall of S. boulardii rich in mannose is not expected to compete for EPEC
adhesion site to enterocytes. Consistently, as shown in this study,
S. boulardii did not significantly modify the number of adherent bacteria. However, S. boulardii significantly
decreased, by 50%, the number of intracellular bacteria. Invasion of
eucaryotic cells is an important virulence mechanism of many enteric
pathogens such as Salmonella, Shigella, and
Listeria species (20). EPEC strains have
traditionally been considered noninvasive, but accumulating evidence
raises doubt about this assumption. Intracellular EPEC have been
observed in animal models (30, 39) and in biopsies from
infected humans (18, 40). In vitro studies have revealed that EPEC are also capable of invading Hep-2, HeLa, and CaCo2 cells
(2, 15, 35), supporting our results with T84 cells. As
previously demonstrated for Salmonella enterica serovar
Typhimurium and Yersinia pseudotuberculosis, EPEC strains
take advantage of host signaling mechanisms to gain entry into the cell
(reviewed in reference 4). We thus investigated the
effect of S. boulardii on a cellular event(s) occurring
after EPEC adhesion. As shown here, EPEC induced tyrosine
phosphorylations of several proteins in T84 cells. Tyrosine
phosphorylations of proteins during EPEC infection have been already
reported in HeLa cells (35). These authors identified three
tyrosine-phosphorylated proteins: a 90-kDa protein (Hp90), representing
the major phosphorylation substrate, and two minor phosphorylated
proteins of 39 kDa (Hp39) and 72 kDa (Hp72). In contrast to HeLa cells,
Hp90 was not the major phosphorylated substrate in T84 cells.
Tyrosine-phosphorylated proteins with molecular masses of 32 and 72 kDa
probably corresponding to Hp32 and Hp72 were also detected in
EPEC-infected T84 cells. As reported in this study EPEC triggered
tyrosine phosphorylation of several other proteins with apparent masses
of 130, 120, 100, 60, and 52 kDa that had not yet been reported. These
proteins were barely phosphorylated when the infection was performed in the presence of yeast cells. Of these substrates we identified SHC, the
upstream regulatory protein of the ERK1/2 MAP kinases, as a new
phosphorylated substrate in EPEC-infected cells. MAP kinases are
central in many host responses, including the mitogenic response to
growth factors, the regulation of cytokine responses, stress responses,
and cytoskeletal reorganization (14). Recently, MAP kinases
have been implicated in the host response to bacterial infection
(26, 38). As reported in this study, EPEC induces the
activation of ERK1/2 MAP kinases in T84 cells. SHC isoforms were less
phosphorylated in cells infected in the presence of S. boulardii: consequently, the activation of ERK1/2 MAP kinases was
decreased in the presence of yeast. Activation of ERK1/2 MAP kinases
has been implicated in the invasion process of L. monocytogenes, since a specific inhibitor of this pathway, namely,
PD 98059, blocks invasion of HeLa cells by these bacteria
(38). That study demonstrated that PD 98059 had no effect on
the adherence of EPEC to host cells but significantly lowered EPEC
invasion of T84 cells, underscoring the implication, at least in part,
of ERK1/2 MAP kinases in this process. Thus, a decrease in the
phosphorylation of ERK1/2 proteins may account for the lowering of the
number of intracellular bacteria observed in cells infected in the
presence of yeasts.
Since intracellular bacteria do not play an important role in the
reduction of transepithelial resistance (9), the decrease in
the number of intracellular bacteria cannot explain the presence of
transepithelial resistance in cells infected in the presence of yeasts.
Tyrosine phosphorylation of proteins is implicated in intercellular
junction organization and modulation of the paracellular barrier
(11). Other EPEC-induced tyrosine-phosphorylated proteins, dephosphorylated in the presence of yeasts, might therefore be implicated in the maintenance of transepithelial resistance. Future studies will be aimed at the identification of these proteins and the
underlying mechanism of yeast-induced dephosphorylation.
 |
ACKNOWLEDGMENTS |
This study was supported by Laboratories BIOCODEX, the
Région Provence-Alpes Côte d'Azur, the Conseil
Général des Alpes Maritimes, the Faculté de
Médecine de l'Université de Nice-Sophia Antipolis, and the
Centre Hospitalier Régional de Nice.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratoire de
Gastroentérologie, Université de Nice-Sophia Antipolis, 28 Avenue de Valombrose, 06107 Nice Cedex 2, France. Phone: (33)
4-93-37-76-95. Fax: (33) 4-93-81-77-10. E-mail:
czerucka{at}unice.fr.
Editor:
S. H. E. Kaufmann
 |
REFERENCES |
| 1.
|
Alessi, D. R.,
A. Cuenda,
P. Cohen,
D. T. Dudley, and A. R. Saltiel.
1995.
PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo.
J. Biol. Chem.
270:27489-27494[Abstract/Free Full Text].
|
| 2.
|
Andrade, J. R. C.,
V. D. Da Viega,
M. R. De Santa Rosa, and I. Suassuna.
1989.
An endocytic process in Hep-2 cells induced by enteropathogenic Escherichia coli.
J. Med. Microbiol.
28:49-57[Abstract/Free Full Text].
|
| 3.
|
Bieber, D.,
S. W. Sandra,
C.-Y. Hu,
W. J. Murray,
T. Tobe,
R. Fernandez, and G. K. Schoolnik.
1998.
Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli.
Science
280:2114-2118[Abstract/Free Full Text].
|
| 4.
|
Bliska, J. B., and S. Falkow.
1993.
The role of host tyrosine phosphorylation in bacterial pathogenesis.
Trends Genet.
9:85-89[CrossRef][Medline].
|
| 5.
|
Bocciardi, R.,
B. Mograbi,
B. Pasini,
M. G. Borrello,
M. A. Pierotti,
I. Bourget,
S. Fisher,
G. Romeo, and B. Rossi.
1997.
The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck.
Oncogene
15:2257-2265[CrossRef][Medline].
|
| 6.
|
Brugier, S., and F. Patte.
1975.
Antagonisme in vitro entre l'ultra-levure et différents germes bactériens.
Med. Paris
45:61-66.
|
| 7.
|
Buts, J. P.,
P. Bernasconi,
J. P. Vaerman, and C. Dive.
1990.
Stimulation of secretory IgA and secretory component of immunoglobulin in small intestine of rats treated with Saccharomyces boulardii.
Dig. Dis. Sci.
35:251-256[CrossRef][Medline].
|
| 8.
|
Buts, J. P.,
P. Bernasconi,
M. P. Van Craynest,
P. Maldague, and R. deMeyer.
1986.
Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii.
Pediatr. Res.
20:192-196[Medline].
|
| 9.
|
Canil, C.,
I. Rosenshine,
S. Rushkowski,
M. S. Donnenberg,
J. B. Kaper, and B. Finlay.
1993.
Enteropathogenic Escherichia coli decreases transepithelial electrical resistance of polarized epithelial monolayers.
Infect. Immun.
61:2755-2762[Abstract/Free Full Text].
|
| 10.
|
Castex, F.,
G. Corthier,
S. Jouvert,
G. W. Elmer,
J. Guibal,
F. Lucas, and M. Bastidel.
1989.
Prevention of experimental pseudomembranous cecitis by Saccharomyces boulardii: topographical histology of the mucosa, bacterial counts, and analysis of toxin production.
Microecol. Ther.
18:113-116.
|
| 11.
|
Collares-Buzato, C. B.,
M. A. Jepson,
N. L. Simmons, and B. H. Hirst.
1998.
Increased tyrosine phosphorylation causes redistribution of adherence junction and tight junction proteins and perturbs paracellular barrier function in MDCK epithelia.
Eur. J. Cell Biol.
76:85-92[Medline].
|
| 12.
|
Crane, J. K.,
S. Majumdar, and D. F. Pickhardt, III.
1999.
Host cell death due to enteropathogenic Escherichia coli has features of apoptosis.
Infect. Immun.
67:2575-2584[Abstract/Free Full Text].
|
| 13.
|
Czerucka, D.,
J. L. Nano,
P. Bernasconi, and P. Rampal.
1989.
Réponse à la toxine cholérique de deux lignées de cellules épithéliales intestinales. Effet de Saccharomyces boulardii.
Gastroenterol. Clin. Biol.
13:383-387[Medline].
|
| 14.
|
Davis, R. J.
1993.
The mitogen-activated protein kinase signal transduction pathway.
J. Biol. Chem.
268:14553-14556[Free Full Text].
|
| 15.
|
Donnenberg, M. S.,
A. Donohue-Rolfe, and G. T. Keusch.
1989.
Epithelial cell invasion: overlooked property of enteropathogenic Escherichia coli (EPEC) associated with the EPEC adherence factor.
J. Infect. Dis.
160:452-459[Medline].
|
| 16.
|
Dytoc, M. T.,
L. Fedorko, and P. M. Sherman.
1994.
Signal transduction in human epithelial cells infected with attaching and effacing Escherichia coli in vitro.
Gastroenterology
106:1150-1161[Medline].
|
| 17.
|
Elmer, G. W.,
C. M. Surawicz, and L. V. McFarland.
1996.
Biotherapeutic agents: a neglected modality for the treatment and prevention of selected intestinal and vaginal infections.
JAMA
275:870-876[Abstract/Free Full Text].
|
| 18.
|
Fagundes-Neto, U.,
E. Freymuller,
M. S. V. Gatti,
L. G. Schmitz, and I. Scaletsky.
1995.
Enteropathogenic Escherichia coli O111ab/H2 penetrates the small bowel epithelium in an infant with acute diarrhoea.
Acta Pediatr.
84:453-455[Medline].
|
| 19.
|
Falkow, S.,
P. Small,
R. Isberg,
S. F. Hayes, and D. A. Corwin.
1987.
A molecular strategy for the study of bacterial invasion.
Rev. Infect. Dis.
9(Suppl.):S450-S455.
|
| 20.
|
Finlay, B. B., and S. Falkow.
1988.
Comparison of the invasion strategies used by Salmonella choleraesuis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication.
Biochimie
70:1089-1099[Medline].
|
| 21.
|
Finlay, B. B., and S. Falkow.
1990.
Salmonella interaction with polarized human intestinal Caco-2 epithelial cells.
J. Infect. Dis.
162:1096-1106[Medline].
|
| 22.
|
Finlay, B. B.,
I. Rosenshine,
M. S. Donnenberg, and J. B. Kaper.
1992.
Cytoskeletal composition of attaching and effacing lesions associated with enteropathogenic Escherichia coli adherence to HeLa cells.
Infect. Immun.
60:2541-2543[Abstract/Free Full Text].
|
| 23.
|
Foubister, V.,
I. Rosenshine, and B. B. Finlay.
1994.
A diarrheal pathogen, enteropathogenic Escherichia coli (EPEC) triggers a flux of inositol phosphates in infected epithelial cells.
J. Exp. Med.
179:993-998[Abstract/Free Full Text].
|
| 24.
|
Gedek, B. R.
1999.
Adherence of Escherichia coli serogroup O157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii.
Mycoses
42:261-264[CrossRef][Medline].
|
| 25.
|
Gedek, B. R., and W. Amselgruber.
1990.
Mikrobieller antagonismus: zur eliminierung von enteropathogenen E. coli-keimen and Salmonella aus dem darm durch Saccharomyces boulardii, p. 184-186.
In
R. Ottenjann, J. Muller, and J. Seifert (ed.), Okosystem Darm II-Mykrobiologie, Immunologie, Morphologie. Springer-Verlag, Berlin, Germany.
|
| 26.
|
Hobbie, S.,
L. M. Chen,
R. J. Davis, and J. E. Galan.
1997.
Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells.
J. Immunol.
159:5550-5559[Abstract].
|
| 27.
|
Knutton, S.,
T. Baldwin,
P. H. Williams, and A. S. McNeish.
1989.
Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.
Infect. Immun.
57:1290-1298[Abstract/Free Full Text].
|
| 28.
|
Mandel, L. J.,
R. Bacallao, and G. Zampighi.
1993.
Uncoupling of the molecular "fence" and paracellular "gate" functions in epithelial tight junctions.
Nature
361:552-555[CrossRef][Medline].
|
| 29.
|
McFarland, L. V., and P. Bernasconi.
1993.
Saccharomyces boulardii: a review of an innovative biotherapeutic agent.
Microb. Ecol. Health Dis.
6:157-171.
|
| 30.
|
Moon, H. W.,
S. C. Whipp,
R. A. Argenzio,
M. M. Levine, and R. A. Gianella.
1983.
Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines.
Infect. Immun.
41:1340-1351[Abstract/Free Full Text].
|
| 31.
|
Nataro, J., and J. B. Kaper.
1998.
Diarrheagenic Escherichia coli.
Clin. Microbiol. Rev.
11:142-201[Abstract/Free Full Text].
|
| 32.
|
Philpott, D. J.,
D. M. McKay,
P. M. Sherman, and M. H. Perdue.
1996.
Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions.
Am. J. Physiol.
33:G634-G645.
|
| 33.
|
Rodrigues, A. C. P.,
R. M. Nardi,
E. A. Bambirra,
E. C. Viera, and J. R. Nicoli.
1996.
Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice.
J. Appl. Bacteriol.
91:251-256.
|
| 34.
|
Rosa, A. C.,
A. T. Mariano,
A. Tibana,
T. A. Gomes, and J. R. Andrade.
1998.
Enteropathogenicity markers in Escherichia coli isolated from infants with acute diarrhoea and healthy controls in Rio de Janeiro, Brazil.
J. Med. Microbiol.
47:781-790[Abstract/Free Full Text].
|
| 35.
|
Rosenshine, I.,
M. S. Donnenberg,
J. B. Kaper, and B. B. Finlay.
1992.
Signal transduction between enteropathogenic Escherichia coli (EPEC) and epithelial cells: EPEC induces tyrosine phosphorylation of host cell proteins to initiate cytoskeletal rearrangement and bacterial uptake.
EMBO J.
11:3551-3560[Medline].
|
| 36.
|
Scaletsky, I.,
M. L. Silva, and L. R. Trabulski.
1984.
Distinctive patterns of adherence of enteropathogenic Escherichia coli to HeLa cells.
Infect. Immun.
45:534-536[Abstract/Free Full Text].
|
| 37.
|
Spitz, J.,
R. Yuhan,
A. Koutsouris,
C. Blatt,
J. Alverdy, and G. Hecht.
1995.
Enteropathogenic Escherichia coli adherence to intestinal monolayers diminishes barrier function.
Am. J. Physiol.
31:G374-G379.
|
| 38.
|
Tang, P.,
C. L. Sutherland,
M. R. Gold, and B. B. Finlay.
1998.
Listeria monocytogenes invasion of epithelial cells requires the MEK-1/ERK-2 mitogen-activated protein kinase pathway.
Infect. Immun.
66:1106-1112[Abstract/Free Full Text].
|
| 39.
|
Tzipori, S.,
R. M. Robins-Browne,
G. Gonis,
J. Hayes,
M. Withers, and E. McCartney.
1985.
Enteropathogenic Escherichia coli enteritis: evaluation of the gnotobiotic piglet as a model of human infection.
Gut
26:570-578[Abstract/Free Full Text].
|
| 40.
|
Ulshen, M. H., and J. L. Rollo.
1980.
Pathogenesis of Escherichia coli gastroenteritis in man another mechanism.
N. Engl. J. Med.
302:99-101[Medline].
|
| 41.
|
Yuhan, R.,
A. Koutsouris,
S. D. Savkovic, and G. Heicht.
1997.
Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability.
Gastroenterology
113:1873-1882[CrossRef][Medline].
|
| 42.
|
Zychlinsky, A., and P. Sansonetti.
1997.
Apoptosis in bacterial pathogenesis.
J. Clin. Investig.
100:493-496[Medline].
|
Infection and Immunity, October 2000, p. 5998-6004, Vol. 68, No. 10
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Mumy, K. L., Chen, X., Kelly, C. P., McCormick, B. A.
(2008). Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events. Am. J. Physiol. Gastrointest. Liver Physiol.
294: G599-G609
[Abstract]
[Full Text]
-
Wu, X., Vallance, B. A., Boyer, L., Bergstrom, K. S. B., Walker, J., Madsen, K., O'Kusky, J. R., Buchan, A. M., Jacobson, K.
(2008). Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am. J. Physiol. Gastrointest. Liver Physiol.
294: G295-G306
[Abstract]
[Full Text]
-
Edwards-Ingram, L., Gitsham, P., Burton, N., Warhurst, G., Clarke, I., Hoyle, D., Oliver, S. G., Stateva, L.
(2007). Genotypic and Physiological Characterization of Saccharomyces boulardii, the Probiotic Strain of Saccharomyces cerevisiae. Appl. Environ. Microbiol.
73: 2458-2467
[Abstract]
[Full Text]
-
Martins, F. S., Rodrigues, A. C. P., Tiago, F. C. P., Penna, F. J., Rosa, C. A., Arantes, R. M. E., Nardi, R. M. D., Neves, M. J., Nicoli, J. R.
(2007). Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. J Med Microbiol
56: 352-359
[Abstract]
[Full Text]
-
Hanajima-Ozawa, M., Matsuzawa, T., Fukui, A., Kamitani, S., Ohnishi, H., Abe, A., Horiguchi, Y., Miyake, M.
(2007). Enteropathogenic Escherichia coli, Shigella flexneri, and Listeria monocytogenes Recruit a Junctional Protein, Zonula Occludens-1, to Actin Tails and Pedestals. Infect. Immun.
75: 565-573
[Abstract]
[Full Text]
-
Chen, X., Kokkotou, E. G., Mustafa, N., Bhaskar, K. R., Sougioultzis, S., O'Brien, M., Pothoulakis, C., Kelly, C. P.
(2006). Saccharomyces boulardii Inhibits ERK1/2 Mitogen-activated Protein Kinase Activation Both in Vitro and in Vivo and Protects against Clostridium difficile Toxin A-induced Enteritis. J. Biol. Chem.
281: 24449-24454
[Abstract]
[Full Text]
-
Sherman, P. M., Johnson-Henry, K. C., Yeung, H. P., Ngo, P. S. C., Goulet, J., Tompkins, T. A.
(2005). Probiotics Reduce Enterohemorrhagic Escherichia coli O157:H7- and Enteropathogenic E. coli O127:H6-Induced Changes in Polarized T84 Epithelial Cell Monolayers by Reducing Bacterial Adhesion and Cytoskeletal Rearrangements. Infect. Immun.
73: 5183-5188
[Abstract]
[Full Text]
-
Resta-Lenert, S, Barrett, K E
(2003). Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut
52: 988-997
[Abstract]
[Full Text]
-
Dahan, S., Dalmasso, G., Imbert, V., Peyron, J.-F., Rampal, P., Czerucka, D.
(2003). Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells. Infect. Immun.
71: 766-773
[Abstract]
[Full Text]
-
Crane, J. K., Olson, R. A., Jones, H. M., Duffey, M. E.
(2002). Release of ATP during host cell killing by enteropathogenic E. coli and its role as a secretory mediator. Am. J. Physiol. Gastrointest. Liver Physiol.
283: G74-G86
[Abstract]
[Full Text]
-
Dahan, S., Busuttil, V., Imbert, V., Peyron, J.-F., Rampal, P., Czerucka, D.
(2002). Enterohemorrhagic Escherichia coli Infection Induces Interleukin-8 Production via Activation of Mitogen-Activated Protein Kinases and the Transcription Factors NF-{kappa}B and AP-1 in T84 Cells. Infect. Immun.
70: 2304-2310
[Abstract]
[Full Text]
-
Stevens, D. A., Czerucka, D.
(2001). Saccharomyces and Enteropathogenic Escherichia coli. Infect. Immun.
69: 4192-4192
[Full Text]
-
Czerucka, D., Dahan, S., Mograbi, B., Rossi, B., Rampal, P.
(2001). Implication of Mitogen-Activated Protein Kinases in T84 Cell Responses to Enteropathogenic Escherichia coli Infection. Infect. Immun.
69: 1298-1305
[Abstract]
[Full Text]